Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedAug 02, 2026
DataAggregated Company Financials
Companies14
  • 7D2.0%
  • 3M9.9%
  • 1Y-4.4%
  • YTD-2.8%

Over the last 7 days, the Healthcare industry has risen 2.0%, driven by gains from Fisher & Paykel Healthcare of 3.2%. However, the industry is down 4.4% over the past year. As for the next few years, earnings are expected to grow by 21% per annum.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 03 Aug 2026NZ$34.3bNZ$19.9bNZ$824.9m16.6x41.6x1.7x
Wed, 01 Jul 2026NZ$33.2bNZ$20.2bNZ$829.9m15.9x39.9x1.6x
Fri, 29 May 2026NZ$31.9bNZ$20.1bNZ$815.8m27x39.1x1.6x
Sun, 26 Apr 2026NZ$31.2bNZ$20.0bNZ$452.0m18.1x69.1x1.6x
Tue, 24 Mar 2026NZ$31.9bNZ$19.8bNZ$448.8m18.1x71.1x1.6x
Thu, 19 Feb 2026NZ$32.2bNZ$18.5bNZ$538.6m20x59.9x1.7x
Sat, 17 Jan 2026NZ$35.9bNZ$18.4bNZ$535.3m21.2x67x2x
Mon, 15 Dec 2025NZ$35.1bNZ$18.1bNZ$531.7m21.6x65.9x1.9x
Wed, 12 Nov 2025NZ$35.5bNZ$18.1bNZ$579.6m19.7x61.2x2x
Fri, 10 Oct 2025NZ$35.2bNZ$17.9bNZ$575.8m19.5x61x2x
Sun, 07 Sep 2025NZ$34.9bNZ$17.5bNZ$569.7m18.3x61.2x2x
Tue, 05 Aug 2025NZ$35.5bNZ$17.6bNZ$571.7m19.1x62.1x2x
Thu, 03 Jul 2025NZ$36.1bNZ$17.5bNZ$568.3m16.4x63.6x2.1x
Sat, 31 May 2025NZ$34.7bNZ$17.4bNZ$568.1m17.2x61.1x2x
Mon, 28 Apr 2025NZ$33.0bNZ$17.2bNZ$652.5m15.8x50.6x1.9x
Wed, 26 Mar 2025NZ$32.0bNZ$17.5bNZ$659.1m17.5x48.6x1.8x
Fri, 21 Feb 2025NZ$35.7bNZ$17.6bNZ$707.5m16.7x50.4x2x
Sun, 19 Jan 2025NZ$37.2bNZ$18.3bNZ$735.3m14.2x50.6x2x
Tue, 17 Dec 2024NZ$35.8bNZ$18.2bNZ$733.7m13.2x48.8x2x
Thu, 14 Nov 2024NZ$38.2bNZ$18.2bNZ$967.6m17.4x39.5x2.1x
Sat, 12 Oct 2024NZ$37.8bNZ$18.3bNZ$968.0m19.9x39.1x2.1x
Mon, 09 Sep 2024NZ$37.0bNZ$17.9bNZ$961.4m20.5x38.5x2.1x
Wed, 07 Aug 2024NZ$33.7bNZ$17.5bNZ$973.5m19.1x34.6x1.9x
Fri, 05 Jul 2024NZ$29.7bNZ$17.6bNZ$974.8m16.5x30.5x1.7x
Sun, 02 Jun 2024NZ$30.0bNZ$17.3bNZ$1.2b12.9x24.9x1.7x
Tue, 30 Apr 2024NZ$30.4bNZ$17.4bNZ$1.3b24x23.6x1.7x
Thu, 28 Mar 2024NZ$29.4bNZ$17.3bNZ$1.3b23.4x22.9x1.7x
Sat, 24 Feb 2024NZ$28.4bNZ$16.9bNZ$1.1b18.2x25.1x1.7x
Mon, 22 Jan 2024NZ$28.8bNZ$16.7bNZ$1.1b22.8x25.5x1.7x
Wed, 20 Dec 2023NZ$28.7bNZ$16.7bNZ$1.1b23.4x25.4x1.7x
Fri, 17 Nov 2023NZ$28.5bNZ$16.5bNZ$1.1b27x25.7x1.7x
Sun, 15 Oct 2023NZ$27.3bNZ$16.3bNZ$1.1b31x24.7x1.7x
Tue, 12 Sep 2023NZ$27.8bNZ$16.5bNZ$1.1b28.9x25.1x1.7x
Thu, 10 Aug 2023NZ$29.6bNZ$15.8bNZ$1.1b29x27.6x1.9x
Price to Earnings Ratio

27.6x


Total Market Cap: NZ$29.6bTotal Earnings: NZ$1.1bTotal Revenue: NZ$15.8bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 45.1x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 41.6x which is lower than its 3-year average PE of 45.1x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.4% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market-0.64%
Healthcare2.01%
Pharma11.95%
Medical Equipment3.21%
Biotech1.89%
Healthcare Services-1.37%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.3x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FPH Fisher & Paykel HealthcareNZ$40.693.2%
+NZ$745.9m		13.0%PE51x
AFT AFT PharmaceuticalsNZ$4.8112.6%
+NZ$56.6m		76.8%PE34.2x
EBO EBOS GroupNZ$22.040.2%
+NZ$8.3m		-44.9%PE16.6x
PEB Pacific EdgeNZ$0.271.9%
+NZ$6.2m		159.6%PS25.8x
RUA Rua BioscienceNZ$0.0417.9%
+NZ$1.0m		-8.9%PS5.8x

Latest News

TAH
NZ$4.47
Third Age Health Services
7D
-1.1%
1Y
-0.7%
AFT
NZ$4.81
AFT Pharmaceuticals
7D
12.6%
1Y
76.8%
FPH
NZ$40.69
Fisher & Paykel Healthcare
7D
3.2%
1Y
13.0%
Narrative Update • Jul 22

FPH: Removal From Conviction List Will Pressure Overvalued Shares

Analysts have revised their fair value estimate for Fisher & Paykel Healthcare to NZ$30.59 from NZ$29.31, citing updated assumptions around discount rates, revenue growth, profit margins and a lower future P/E multiple, and also reflecting the recent removal of the stock from a regional conviction list. What's in the News Fisher & Paykel Healthcare declared a dividend of NZ$0.38823529 per share for the six months ended March 31, 2026, according to company disclosures.
SUM
NZ$8.33
Summerset Group Holdings
7D
-1.1%
1Y
-26.7%
RYM
NZ$2.14
Ryman Healthcare
7D
-4.9%
1Y
-14.4%
RUA
NZ$0.041
Rua Bioscience
7D
7.9%
1Y
-8.9%
MEE
NZ$0.05
Me Today
7D
16.3%
1Y
-33.3%
EBO
NZ$22.04
EBOS Group
7D
0.2%
1Y
-44.9%
Narrative Update • Jul 08

EBO: Distribution Contracts And Animal Care Expansion Will Support Future Upside Potential

Analysts have adjusted their price target on EBOS Group to reflect a revised fair value of NZ$36.57, down from NZ$41.16. They cite updated assumptions for discount rates, revenue growth, profit margins, and future P/E multiples.
TRU
NZ$0.016
TruScreen Group
7D
-5.9%
1Y
-11.1%
PEB
NZ$0.27
Pacific Edge
7D
1.9%
1Y
159.6%
OCA
NZ$0.76
Oceania Healthcare
7D
-1.3%
1Y
9.4%
Narrative Update • Jun 26

OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings

Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.
PHL
NZ$0.69
Promisia Healthcare
7D
-0.7%
1Y
52.2%
Analysis Article • Jun 04

We Think That There Are Issues Underlying Promisia Healthcare's (NZSE:PHL) Earnings

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...